The bacterial phosphoenolpyruvate phosphotransferase system (PTS) is a highly conserved phosphotransfer cascade that participates in the transport and phosphorylation of selected carbohydrates and modulates many cellular functions in response to carbohydrate availability. It plays a role in the virulence of many bacterial pathogens. Components of the carbohydrate-specific PTS include the general cytoplasmic components enzyme I (EI) and histidine protein (HPr), the sugar-specific cytoplasmic components enzymes IIA (EIIA) and IIB (EIIB), and the sugar-specific membrane-associated multisubunit components enzymes IIC (EIIC) and IID (EIID). Many bacterial genomes also encode a parallel PTS pathway that includes the EI homolog EI Ntr , the HPr homolog NPr, and the EIIA homolog EIIA Ntr . This pathway is thought to be nitrogen specific because of the proximity of the genes encoding this pathway to the genes encoding the nitrogen-specific factor 54 . We previously reported that phosphorylation of HPr and FPr by EI represses Vibrio cholerae biofilm formation in minimal medium supplemented with glucose or pyruvate. Here we report two additional PTS-based biofilm regulatory pathways that are active in LB broth but not in minimal medium. These pathways involve the glucose-specific enzyme EIIA (EIIA Glc ) and two nitrogen-specific EIIA homologs, EIIA Ntr1 and EIIA Ntr2 . The presence of multiple, independent biofilm regulatory circuits in the PTS supports the hypothesis that the PTS and PTS-dependent substrates have a central role in sensing environments suitable for a surface-associated existence.
Attachment of a free-swimming bacterium to a surface, which is termed biofilm formation, is the result of a complex decision tree that occurs when a bacterium encounters a surface (19) . Environmental signals dictate the decisions made at each branch point. The advantages afforded to a bacterium by surface attachment depend on the environmental niche of the bacterium being studied, and the environmental signals that induce biofilm formation reflect this.
Formation of a multilayer bacterial biofilm often requires synthesis of an extracellular matrix composed of biological polymers that enhance interbacterium attachment. These extracellular polymers may be proteins, polysaccharides, and/or DNA (7) . Synthesis of the biofilm matrix is often tightly regulated. The environmental activators of many signaling pathways that modulate multilayer biofilm accumulation have been identified. These activators include specific carbohydrates, quorum-sensing molecules, nucleic acids and their precursors, and polyamines (1, 6, 9, 13, 15, 17, 18, 26, 31, 33, 35, 41, 45, 53) . However, there are many known biofilm regulatory pathways for which no environmental activator has been identified yet.
The phosphoenolpyruvate phosphotransferase system (PTS) is a multicomponent phosphotransfer cascade that mediates transport and phosphorylation of selected sugars, such as glucose, sucrose, mannose, and N-acetylglucosamine (10) . In addition, it has been implicated in the formation of biofilms by diverse organisms (1, 2, 17, 31, 42) . Phosphate enters the PTS through transfer from phosphoenolpyruvate to the first PTS component, the phosphoenolpyruvate-protein phosphotransferase or enzyme I (EI). EI in turn transfers the phosphate group to another component of the PTS, histidine protein (HPr). Many bacterial genomes also encode a protein homologous to HPr termed FPr, which is preferred for transport of fructose through the PTS. HPr and FPr transfer phosphate to a number of enzymes II, which are multisubunit, membraneassociated complexes that carry out transport and phosphorylation of specific PTS substrates. Because transport of PTS substrates rapidly depletes the PTS of phosphorylated intermediates, the phosphorylation states of PTS components serve as cytoplasmic reporters of environmental nutrient availability. These reporters then modulate cellular functions such as chemotaxis (60) , uptake and catabolism of PTS-independent carbohydrates (1, 12, 39) , and glycogen breakdown (54, 55) .
The genomes of many Gram-negative organisms contain genes encoding another phosphotransfer cascade that is homologous to the carbohydrate-transporting PTS. Because these genes are close to rpoN, which encodes the sigma factor involved in transcription of many genes required for nitrogen assimilation, this phosphotransfer cascade is termed the nitrogen-related PTS or PTS Ntr (22, 49, 50) . The components of this phosphotransfer cascade include EI Ntr , NPr, and EIIA Ntr . Unlike the carbohydrate-transporting PTS, PTS Ntr does not include membrane-associated components and, therefore, does not partic-ipate directly in transport of nutrients into the cell. Rather, its primary function in the cell is thought to be regulatory (22, 24, 25, 32, 44) . While the breadth and overarching goal of the PTS Ntr have not been defined, transfer of phosphate between the two PTS cascades may be one mechanism by which the PTS Ntr influences cellular function (46) . Vibrio cholerae is a Gram-negative bacterium whose natural habitat includes environments with low and intermediate salinities, such as ponds and estuaries (8) . There is some evidence that V. cholerae forms a multilayer, exopolysaccharide-based biofilm in freshwater environments (20) . The exopolysaccharide is referred to as VPS (Vibrio polysaccharide), and the region of the V. cholerae genome containing many of the genes required to make the biofilm matrix is known as the vps island (64) .
When pathogenic V. cholerae is ingested by humans in contaminated food or water, the diarrheal disease cholera results. While many studies of human and murine infection have suggested that proteins required for biofilm matrix synthesis are expressed in vivo (14, 30) , no study has found that these proteins are essential for colonization of the mammalian intestine (16, 23, 63) .
The V. cholerae genome encodes 25 PTS components, including two EI homologs, three HPr homologs, and nine EIIA homologs (Fig. 1) . A role in carbohydrate transport has been established for a subset of these components (16) . We recently Furthermore, proteins belonging to the same EIIA superfamily are color coded (blue, glucose superfamily; violet, mannitol-fructose superfamily; yellow, lactose superfamily). Sugar specificities are indicated for PTS components if they are known (16) . Parentheses indicate presumptive specificities. The VC1824 HPr-like domain is surrounded by a dashed line to indicate its low level of similarity to HPr. The sugar specificity of VC1281 is based on previously described data (3). NAG, N-acetylglucosamine. discovered that supplementation of minimal medium (MM) with PTS sugars activates transcription of the vps genes and formation of a multilayer biofilm (40) . Furthermore, we found that phosphorylated form of EI represses V. cholerae biofilm formation in minimal medium (17) . Subsequent biofilm assays conducted with Luria-Bertani (LB) broth suggested that there are additional PTS-based regulatory pathways. Here we define three PTS-based biofilm regulatory pathways that are present when this medium is used. These studies illustrate the complexity of the regulation of V. cholerae biofilm accumulation by PTS components and underscore the importance of carbohydrates as signals in the decision of V. cholerae cells to join a biofilm.
MATERIALS AND METHODS
Bacterial strains, plasmids, and media. The bacterial strains and plasmids used in this study are listed in Table 1 . V. cholerae strain PW357 was used for biofilm assays. Bacteria were cultivated in Luria-Bertani broth or minimal medium supplemented with 0.5% (wt/vol) glucose or pyruvate (Sigma) (17) . Where indicated below, the medium was also supplemented with streptomycin (100 g/ml), ampicillin (50 or 100 g/ml), or L-arabinose (0.04% wt/vol). Where specified below, a 0.1 M phosphate-buffered saline solution (PBS) (pH 7.0) was used.
Construction of mutants. The plasmid used to make the ⌬mlc mutant, pKEK⌬mlc, was generously provided by J. Reidl (3) . All other plasmids used in the construction of insertion and in-frame deletion mutants were available in our laboratory (16, 17) . Suicide plasmids were used to generate insertion and inframe deletion mutants by single and double homologous recombination, respectively.
Construction of rescue plasmids. Plasmids used for rescue experiments, which are listed in Table 1 , were constructed as previously described (17, 61) using the primers listed in Table 2 . Briefly, the native sequence of the targeted gene was amplified by PCR and cloned into pBAD-TOPO (Invitrogen) using the manufacturer's protocol. Point mutation sequences were generated by amplification of two gene fragments using internal primers with overlapping sequences containing the desired mutation. The two fragments were joined using the splicing by overlap extension (SOE) technique and cloned into pBAD-TOPO (Invitrogen) using the manufacturer's protocol. The sequence of the inserted fragment was confirmed by amplification and sequence analysis. The rescue plasmids were then introduced into V. cholerae strains by electroporation, and transformants were selected on LB agar supplemented with ampicillin. A pBAD-TOPO vector containing an antisense fragment of the coding sequence for EIIA Glc(H91A) was used as a control plasmid for rescue experiments. Expression of the cloned protein was evaluated by Western blot analysis as previously described (16) .
Quantitative analysis of total growth and biofilm formation. Quantification of surface association was performed as described previously (20) . Briefly, the strains were grown overnight on LB agar plates at 27°C. The following morning, the resulting colonies were used to inoculate borosilicate tubes filled with 300 l of LB broth or MM supplemented with glucose or pyruvate. After incubation for 18 to 24 h at 27°C, each planktonic cell suspension was collected, and the planktonic cell density was estimated by measuring the optical density at 655 nm (OD 655 ) using a Benchmark Plus microplate spectrophotometer (Bio-Rad). To quantify the surface-attached cells, 300 l of PBS and a small number of 1-mm glass beads were added to the surface-attached cells remaining in the borosilicate tube, and the cells were dispersed by vortexing. The OD 655 of the resulting cell suspension was measured. Each total growth value represented the sum of the OD 655 recorded for the planktonic and surface-associated cell suspensions. All values are the means of at least three experimental replicates, and standard deviations were determined. Statistical significance was calculated using a two-tailed t test.
Quantification of PTS component transcripts. Wild-type V. cholerae was cultured for 18 h in LB broth or MM supplemented with pyruvate (0.5%, wt/vol). The cells were then pelleted by centrifugation, and total RNA was isolated using an RNeasy kit (Qiagen), followed by RNase-free DNase I treatment to remove contaminating DNA. Reverse transcription-PCR (RT-PCR) was performed using 1 to 2 ng of total RNA with a SuperScriptIII first-strand kit (Invitrogen). Subsequently, 15 ng of the resulting cDNA was used as the template for quantitative PCR using iTaq SYBR green Supermix with ROX (Bio-Rad) and 5 pmol of the relevant primers (Table 2 ) in a 20-l reaction mixture. The level of the clpX (VC1921) transcript was used to normalize all measurements. Templatefree reaction mixtures were included as controls to confirm the absence of contaminating DNA or RNA. The experiments were conducted with a StepOnePlus PCR system (Applied Biosystems) using the following steps: (i) 95°C for 10 min, (ii) 40 cycles of denaturation for 15 s at 95°C and annealing and extension for 1 min at 60°C, and (iii) dissociation curve analysis using temperatures from 60°C to 90°C. Data were analyzed using the StepOne V2.0 software (Applied Biosystems). Measurements were obtained in triplicate.
Measurement of vpsL transcription using a ␤-galactosidase reporter. Strains were inoculated into LB broth to obtain an initial OD 655 of approximately 0.05. Cultures were incubated at 27°C for 4 h with shaking until the OD 655 was approximately 0.5. The OD 655 was determined and subsequently used for normalization of measurements of ␤-galactosidase activity. Fifty or 100 l of each culture was moved to a white 96-well plate (Nunc). Three freeze-thaw cycles were performed, and an equal volume of the ␤-Glo luminescent substrate (Promega) was added to each well. After incubation in the dark at room temperature for 30 min, luminescence was measured with an Infinite 200 spectrophotometer (Tecan). Three experimental replicates were included each time that the experiment was performed, the experiment was repeated three times, and similar results were obtained in the three experiments. Values for a representative experiment are reported below and are the means of three experimental replicates; standard deviations were also determined, and statistical significance was calculated using a two-tailed t test.
RESULTS
The biofilm phenotypes of ⌬EI and ⌬EIIA Glc mutants in LB broth are additive. We first compared biofilm formation in LB broth and minimal medium supplemented with glucose by a ⌬EI mutant, a ⌬EIIA Glc mutant, and a ⌬PTS mutant lacking the genes encoding EI, HPr, and EIIA Glc (Fig. 2 ). Similar to Glc mutant, and a ⌬PTS mutant in minimal medium supplemented with 0.5% (wt/vol) glucose (MM ϩ glucose) and LB broth (LB). The values are the averages of four experimental replicates, and the error bars indicate standard deviations. There was a statistically significant difference (P ϭ 0.0062)between biofilm formation by wild-type V. cholerae and biofilm formation by the ⌬PTS mutant in minimal medium supplemented with glucose (indicated by an asterisk) but not in LB broth (P ϭ 0.116).
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what was observed in minimal medium, in LB broth a ⌬EI mutant exhibited increased surface accumulation compared with wild-type V. cholerae, while a ⌬EIIA Glc mutant exhibited decreased surface accumulation. As previously noted (17) , surface accumulation by a ⌬PTS mutant lacking EI, HPr, and EIIA Glc was increased in minimal medium supplemented with glucose. In contrast, the surface accumulation by the ⌬PTS mutant was similar to that by wild-type V. cholerae in LB broth. This suggested that the biofilm phenotype of the ⌬PTS mutant in LB broth might reflect the additive effects of two opposing regulatory pathways.
Evidence for repression of biofilm accumulation by EI-P and HPr-P in LB broth (regulatory pathway 1). In both minimal medium and LB broth, EI represses biofilm formation (17) . To determine if the phosphorylated form of EI is required for this repression, we measured biofilm formation by a ⌬EI mutant rescued with a control plasmid, with a plasmid carrying a wild-type EI allele, or with a plasmid carrying a mutant EI allele in which phosphorylated histidine 189 had been changed to alanine. As shown in Fig. 3A , while the biofilm phenotype of a ⌬EI mutant was rescued by a wild-type EI allele provided in trans, the EI H189A allele was unable to rescue the biofilm phenotype despite adequate expression of the protein (Fig. 3B ). This suggests that, similar to what was observed in minimal medium (17) , EI-P represses V. cholerae biofilm formation in LB broth. We previously reported that in minimal medium supplemented with glucose, repression of biofilm accumulation by EI becomes apparent only during the stationary phase of growth. This corresponds to the time at which the glucose in the growth medium is depleted (17) and phosphorylated PTS intermediates begin to accumulate. Because PTS substrates are less abundant in LB broth (20) , we predicted that during growth in LB broth, repression of biofilm accumulation by EI-P would be observed much earlier in the growth cycle. As predicted, the difference in biofilm accumulation between wild-type V. cholerae and the ⌬EI mutant occurred during the exponential phase of growth and increased in early stationary phase (Fig. 3C) .
In minimal medium, repression of biofilm formation by EI requires phosphotransfer to either HPr or FPr (16) . Furthermore, this repression occurs at the level of transcription. To determine if phosphotransfer from EI to HPr or FPr contributed to repression of biofilm accumulation in LB broth, we compared biofilm accumulation by wild-type V. cholerae and biofilm accumulation by ⌬HPr, ⌬FPr, and ⌬HPr ⌬FPr mutants. As shown in Fig. 4A , biofilm accumulation by a ⌬HPr mutant was approximately 2-fold greater than that by wild-type V. cholerae, while biofilm formation by a ⌬FPr mutant was not significantly different. To demonstrate that EI is upstream of HPr/FPr in the signaling pathway, we documented that a wildtype EI allele provided in trans repressed biofilm formation by a ⌬EI mutant but was unable to repress biofilm formation in the absence of HPr and FPr (Fig. 4B) . Lastly, we measured activation of the vps genes in wild-type V. cholerae and ⌬EI, ⌬HPr, ⌬FPr, and ⌬HPr ⌬FPr mutants using a chromosomal lacZ reporter fusion to the vpsL promoter. As shown in Fig.  4C , deletion of EI and HPr but not FPr increased transcription of the vps genes. Thus, the regulatory pathway leading to re- pression of biofilm formation and vps gene transcription through phosphorylation of EI and HPr is present in both minimal medium and LB broth. This pathway is referred to in this paper as pathway 1 (see Fig. 14) . Three EIIA homologs regulate biofilm accumulation. To further define regulation of biofilm formation by the PTS, we compared biofilm accumulation in LB broth by wild-type V. cholerae and biofilm accumulation in LB broth by strains having mutations in the FPr gene, which encodes both EIIA and HPr domains, as well as in each of the nine genes in the V. cholerae genome encoding EIIA homologs (Fig. 1) . As shown in Fig. 5 (Fig. 6 ). Pathway 1 was present in both minimal medium and LB broth. However, the transcript levels of the pathway 1 components EI and HPr were lower in LB broth. The transcription of FPr, which does not appear to play a role in regulation of biofilm accumulation in LB broth, was elevated in LB broth compared with minimal medium. The transcription of EIIA Glc was approximately 6-fold greater in LB broth, suggesting that activation of biofilm formation by EIIA Glc in LB broth may be due at least in part to increased transcription of EIIA Glc . Transcription of the PTS components EIIA Ntr1 and EIIA Ntr2 was not increased in LB broth. Therefore, differential transcription of these components does not underlie the observation that they regulate biofilm formation in LB broth but not in minimal medium.
Activation of biofilm formation by EIIA Glc does not require phosphorylation of the conserved histidine at position 91 (regulatory pathway 2). Phosphotransfer through EI and HPr is predicted to lead to EIIA Glc phosphorylation at histidine 91. To determine whether regulation of biofilm formation by EIIA Glc requires phosphorylation of this residue, we studied biofilm accumulation by a ⌬EIIA Glc mutant containing an expression plasmid carrying either a control sequence, a wild-type EIIA Glc allele, an EIIA Glc allele with a histidine-to-alanine mutation at position 91, or an EIIA Glc allele with a histidineto-aspartate mutation at position 91. As shown in Fig. 7A , while these EIIA Glc alleles did not affect the total growth, all of them activated biofilm accumulation in the ⌬EIIA Glc mutant background. To further establish that this rescue was not dependent on either EI or HPr and, therefore, was not part of regulatory pathway 1, we measured activation of biofilm accumulation by the same EIIA Glc alleles in a ⌬PTS mutant background, which lacks EI, HPr, and EIIA Glc (Fig. 7B) . If EIIA Glc were dependent on EI or HPr for activation of biofilm formation, an EIIA Glc allele would be unable to activate biofilm accumulation in the absence of EI or HPr. However, we observed that rescue of biofilm accumulation by the ⌬PTS mutant was possible with each of the three EIIA Glc alleles but not with the control plasmid. Lastly, we demonstrated by Western analysis that all rescue constructs resulted in expression of a full-length protein in the ⌬EIIA Glc mutant background (Fig.  7C) . Therefore, we concluded that activation of biofilm accumulation by EIIA Glc does not require phosphorylation of the conserved histidine at position 91 and that it represents a second, independent PTS-based biofilm regulatory pathway (regulatory pathway 2).
Evidence To further evaluate the presence of this signal transduction pathway, we measured vpsL transcription in wild-type V. cholerae and ⌬EIIBC Glc , ⌬Mlc, and ⌬EIIA Glc mutants, as well as in strains with combinations of these mutations. The results of this experiment are shown in Fig. 9B along with the components of the signal transduction pathway present in each genetic background and the relative amount of vps transcription expected based on functional pathway components. The data support a model in which Mlc activates ⌬EIIA Glc and is repressed by EIIBC Glc . Furthermore, the level of vps transcription in a ⌬EIIA Glc ⌬EIIBC Glc mutant is higher than that in a ⌬EIIA Glc ⌬EIIBC Glc ⌬Mlc mutant, suggesting that Mlc activates vps transcription even in the absence of EIIA Glc . Therefore, an additional pathway must be postulated, in which Mlc activates vpsL transcription independent of EIIA Glc . These pathways are referred to in Fig. 9A as pathways 2a and 2b , respectively.
In general, the measurements of biofilm accumulation correlated well with measurements of vpsL transcription. However, differences were found. First, there was no difference in biofilm accumulation between ⌬EIIA Glc and ⌬Mlc mutants. Second, biofilm formation by strains having mutations in EIIBC Glc as well as in EIIA Glc and/or Mlc all formed biofilms that were slightly but significantly and reproducibly larger than those formed by ⌬EIIA Glc and ⌬Mlc mutants. One possible explanation for these observations is that EIIBC Glc also represses biofilm accumulation at the posttranscriptional level. The complex effect of EIIBC Glc on biofilm formation is currently under investigation.
We hypothesized that if Mlc were partially dependent on EIIA Glc for its effect on biofilm formation, the absence of EIIA Glc would compromise the ability of an mlc allele provided in trans to rescue an Mlc mutation. To test this hypothesis, the following epistasis experiment was performed. We introduced a wild-type allele of mlc into ⌬Mlc, ⌬EIIBC Glc ⌬Mlc, and ⌬EIIA Glc ⌬EIIBC Glc ⌬Mlc mutants. As shown in Fig. 10 , while a control vector had no effect on biofilm accu-
FIG. 8. Evidence for involvement of Mlc and EIIBC
Glc in pathway 2: quantification of total growth and biofilm accumulation by wild-type V. cholerae and various pathway 2 mutants. Biofilm accumulation by the ⌬EI (P ϭ 0.0008) or ⌬EIIBC Glc (P ϭ 0.0001) mutant was significantly greater than that by wild-type V. cholerae (WT). Biofilm accumulation by the ⌬EIIA Glc or ⌬Mlc mutants was significantly less than that by wild-type V. cholerae (P Ͻ 0.0001). Biofilm accumulation by the ⌬EIIA Glc ⌬EIIBC Glc mutant (P ϭ 0.04) or the ⌬EIIA Glc ⌬EIIB-C Glc ⌬Mlc mutant (P ϭ 0.001) was significantly greater than that by the ⌬EIIA Glc mutant. Biofilm accumulation by the ⌬EIIBC Glc ⌬Mlc mutant (P ϭ 0.0006) or the ⌬EIIA Glc ⌬EIIBC Glc ⌬Mlc mutant (P ϭ 0.0005) was significantly greater than that by the ⌬Mlc mutant. The error bars indicate standard deviations. Glc (P Ͻ 0.0001), ⌬EIIBC Glc (P ϭ 0.04), and ⌬Mlc (P ϭ 0.0154) mutants were significantly different from that for wild-type V. cholerae. The vpsL transcription in the ⌬EIIBC Glc ⌬Mlc mutant was significantly different from that in the ⌬EIIBC Glc mutant (P ϭ 0.0003) but not from that in the ⌬Mlc mutant (P ϭ 0.766). The vps transcription in the ⌬EIIA Glc ⌬EIIBC Glc mutant was significantly different from that in the ⌬EIIA Glc mutant (P ϭ 0.032) or the ⌬EIIBC Glc mutant (P Ͻ 0.0001). The vps transcription in the ⌬EIIA Glc ⌬EIIBC Glc ⌬Mlc mutant was significantly different both from that in the ⌬EIIA Glc ⌬EIIBC Glc mutant (P ϭ 0.0086) or the ⌬EIIBC Glc ⌬Mlc mutant (P Ͻ 0.0001) but not from that in the ⌬EIIA Glc mutant (P ϭ 0.415). The models on the right show the predicted impact of each genetic background on vps gene transcription. The relative contributions of the regulatory components to vps gene transcription as shown in panel A were added to obtain the predicted impact of the genetic background on vps gene transcription. WT, wild type; RLU, relative light units. mulation by any of these mutants, introduction of the mlc allele into the ⌬Mlc and ⌬EIIBC Glc ⌬Mlc mutants increased biofilm accumulation approximately 4-fold. In contrast, introduction of the mlc allele into a ⌬EIIA Glc ⌬EIIBC Glc ⌬Mlc mutant increased biofilm accumulation only 2-fold. This result supports our model for pathway 2 in which Mlc activates biofilm accumulation through EIIA Glc -dependent and -independent pathways. EIIA Ntr1 and EIIA Ntr2 repress biofilm accumulation (regulatory pathway 3). The gene encoding EIIA Ntr , which is located close to rpoN, has been found in many bacterial genomes (36, 48, 51) . Mutation of the two V. cholerae EIIA Ntr homologs, EIIA Ntr1 (60% identity and 75% similarity to E. coli EIIA Ntr ) and EIIA Ntr2 (26% identity and 42% similarity to E. coli EIIA Ntr ), resulted in increased biofilm accumulation (Fig. 5) . The conserved histidine residues at position 66 of EIIA Ntr1 and position 172 of EIIA Ntr2 are predicted to be phosphorylated by phosphotransfer from the HPr homolog NPr, which in turn receives a phosphate from EI Ntr . We first determined whether phosphorylation of the conserved histidine was required for the function of EIIA Ntr1 by comparing biofilm accumulation data for ⌬EIIA Ntr1 mutants carrying either a plasmid encoding a control sequence, a wild-type allele of EIIA Ntr1 , a mutant allele having a histidine-to-alanine substitution at residue 66, or a mutant allele having a histidine-to-aspartate substitution at residue 66. Rescue of the biofilm phenotype of a ⌬EIIA Ntr1 mutant was observed with both mutant alleles, as well as with the wild-type allele of EIIA Ntr1 (Fig. 11A) . Furthermore, all alleles of EIIA Ntr1 were well expressed as full-length transcripts (Fig. 11B) . This result suggests that phosphorylation of the conserved histidine at position 66 is not required for repression of biofilm accumulation by EIIA Ntr1 . Based on this observation, we also predicted that the upstream components of the PTS Ntr would not be required for repression of biofilm accumulation by EIIA Ntr1 . To test this hypothesis, we con- Glc ⌬Mlc, and ⌬EIIA Glc ⌬EIIBC Glc ⌬Mlc mutants rescued with either a control vector (pCTL) or a plasmid carrying a wild-type mlc allele (pMlc). Biofilm formation by ⌬Mlc (P Ͻ 0.0001), ⌬EIIBC Glc ⌬Mlc (P Ͻ 0.0001), and ⌬EIIA Glc ⌬EIIBC Glc ⌬Mlc (P ϭ 0.002) mutants rescued with the plasmid carrying the wild-type mlc allele was significantly greater than that by mutants carrying a control vector. The error bars indicate standard deviations.
FIG. 11. Repression of biofilm formation by EIIA
Ntr1 does not require phosphorylation of the conserved histidine at residue 66 and is independent of pathway 1 (biofilm regulatory pathway 3). (A) Quantification of total growth and biofilm accumulation by wild-type V. cholerae or a ⌬EIIA Ntr1 mutant rescued with a control plasmid (pCTL), a plasmid carrying a wild-type EIIA Ntr1 allele (pEIIA Ntr1 ), a plasmid carrying an EIIA Ntr1 allele resulting in an alanine substitution for the histidine at position 66 (pEIIA Ntr1H66A ), a plasmid carrying an EIIA Ntr1 allele resulting in an aspartate substitution for the histidine at position 66 (pEIIA Ntr1H66D ), and a plasmid carrying a wild-type EIIA Ntr2 allele (pEIIA Ntr2 ). Only biofilm accumulation by the ⌬EIIA Ntr1 (pCTL) (P ϭ 0.0003) and ⌬EIIA Ntr1 (pEIIA Ntr2 ) (P ϭ 0.0004) mutants was significantly different from that by wild-type V. cholerae (WT). The error bars indicate standard deviations. (B) Western blot demonstrating that the wild-type and mutant EIIA Ntr1 alleles used in these experiments are well expressed and produce full-length proteins. (C) Quantification of total growth and biofilm accumulation by wildtype V. cholerae and strains having mutations in the other two components of the PTS Ntr , EI Ntr , and NPr. Biofilm accumulation by the two mutants was not significantly different from that by wild-type V. cholerae. (D) Quantification of total growth and biofilm formation by a ⌬EI mutant or a ⌬EI ⌬EIIA Ntr1 mutant rescued with a pBAD plasmid carrying a control sequence (pCTL), a wild-type EI allele (pEI), or a wild-type EIIA Ntr1 allele (pEIIA Ntr1 ). Biofilm accumulation by the ⌬EI ⌬EIIA Ntr1 mutant rescued with a wild-type EI allele was significantly different from that by the ⌬EI ⌬EIIA Ntr1 mutant carrying a control sequence (P ϭ 0.0102).
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on October 15, 2017 by guest http://jb.asm.org/ Downloaded from structed strains having in-frame deletions in EI Ntr and NPr and compared the biofilm accumulation by these strains to that by wild-type V. cholerae. As expected, we found that biofilm accumulation by ⌬EI Ntr and ⌬NPr mutants was not significantly different from that by wild-type V. cholerae (Fig. 11C) .
Because biofilm formation is also repressed by EI, we asked whether EI and EIIA Ntr1 function independently. As shown in Fig. 11D , return of a wild-type EI allele to a ⌬EI ⌬EIIA Ntr1 mutant partially rescued the increased biofilm phenotype, suggesting that EI regulates biofilm formation independent of EIIA Ntr1 . Return of a wild-type EIIA Ntr1 allele did not reduce biofilm formation by a ⌬EI ⌬EIIA Ntr1 mutant. This suggests that the ⌬EI mutation is dominant in the ⌬EI ⌬EIIA Ntr1 mutant. While we have not ruled out a model in which one function of EI is to act downstream of EIIA Ntr1 in a common signaling pathway, we maintain that pathway 1 is independent of pathway 3 because it is present in minimal medium (16) , while pathway 3 is not.
We then asked whether phosphorylation of the conserved histidine at position 172 was required for repression of biofilm accumulation by EIIA Ntr2 . Biofilm accumulation was measured for ⌬EIIA Ntr2 mutants harboring plasmids containing either a control sequence, a wild-type allele of EIIA Ntr2 , an allele of EIIA Ntr2 resulting in substitution of the conserved histidine for alanine at position 172, or an allele of EIIA Ntr2 resulting in substitution of the conserved histidine for aspartate at position 172. As shown in Fig. 12A , the biofilm phenotype of a ⌬EIIA Ntr2 mutant was rescued by the wildtype EIIA Ntr2 allele, as well as by both nonphosphorylatable mutant alleles. Furthermore, all rescue constructs were expressed as full-length proteins (Fig. 12B) .
In other systems, EIIA Ntr has been shown to operate at the transcriptional level (25) . We used ␤-galactosidase assays to measure the effects of the EIIA Ntr homologs on vpsL gene transcription. As shown in Fig. 13 allele provided in trans did rescue the biofilm phenotype of the ⌬EIIA Ntr2 mutant, supporting our conclusion that these two EIIA Ntr homologs function in the same biofilm regulatory pathway (Fig. 12A) . EIIA Ntr2 provided in trans was not able to rescue the ⌬EIIA Ntr1 mutant phenotype (Fig. 11A ). We attribute the inability of EIIA Ntr2 to rescue the phenotype of the ⌬EIIA Ntr1 mutant to its smaller effect on vps gene transcription and biofilm formation.
DISCUSSION
We previously described a PTS-dependent biofilm regulatory pathway present in minimal medium. This pathway requires phosphotransfer from EI to HPr or FPr for action (pathway 1) (16, 17) . Here, we examined regulation of biofilm formation by the PTS in LB broth, a complex medium. Our studies established the action of pathway 1 in V. cholerae biofilms formed in LB broth and also identified two novel PTSdependent pathways, one of which (pathway 2) leads to activation of biofilm formation by EIIA Glc and one of which (pathway 3) results in repression of biofilm formation by EIIA Ntr (Fig. 14) . All three of these pathways regulate transcrip- tion of the vps genes, which encode the biofilm matrix biosynthetic machinery. The regulatory cascade comprising pathway 2 suggests that there are differences from the homologous PTS-dependent regulatory pathway in E. coli, while pathway 3 defines a new role for EIIA Ntr in regulation of bacterial biofilm formation.
In minimal medium, pathway 1 proceeds through EI-P to HPr-P and FPr-P, which have redundant functions. As a result, only a ⌬HPr ⌬FPr mutant forms a biofilm that is distinguishable from that formed by wild-type V. cholerae. In contrast, in LB broth, HPr is the dominant protein in the signal transduction cascade, resulting in increased biofilm accumulation by a ⌬HPr mutant compared with wild-type V. cholerae. This is not due to increased transcription of HPr in LB broth compared with minimal medium (Fig. 6) . Rather, we hypothesize that phosphotransfer through HPr is preferred in LB broth. Alternatively, if pathway 1 remains divergent downstream of HPr and FPr, subsequent components may be responsible for the differences observed in LB broth.
Signaling through pathway 2 results in activation of vps gene transcription. This activation requires EIIA Glc and is observed in the absence of phosphorylation of the conserved histidine residue at position 91. In E. coli, EIIA Glc has two important regulatory functions. EIIA Glc -P potentiates the action of adenylate cyclase to increase intracellular concentrations of cyclic AMP (cAMP), a cofactor of the global regulator, the cAMP receptor protein (CRP) (56) . The unphosphorylated form of EIIA Glc directly blocks transport of non-PTS substrates (52). Here we discovered a phosphorylation-independent regulatory role for EIIA Glc in activation of the vps genes and biofilm formation in V. cholerae. It is unlikely that the regulation is due to activation of adenylate cyclase as multiple studies have shown that cAMP represses rather than activates vps transcription and biofilm formation in V. cholerae (11, 17, 28) .
Regulation of biofilm formation by EIIA
Glc does not require phosphorylation of the conserved histidine at position 91. Therefore, the mechanism by which this function of EIIA Glc is controlled in response to environmental cues is unclear. Because transcription of V. cholerae EIIA Glc is 6-fold greater in LB broth than in minimal medium and 10-fold greater in response to addition of a PTS substrate to minimal medium (17) , one possibility is that the activity of EIIA Glc is regulated by its intracellular abundance.
The results of epistasis experiments and measurements of vpsL transcription are consistent with a model in which Mlc activates biofilm accumulation through EIIA Glc -dependent and EIIA Glc -independent pathways. EIIBC Glc , in turn, inhibits the action of Mlc. Because Mlc is a transcription factor, we hypothesize that it acts at the transcriptional level to increase EIIA Glc activity either directly or indirectly. E. coli Mlc functions as a transcriptional repressor of many PTS components (47, 59) . However, it does not regulate transcription of EIIA Glc . E. coli EIIBC Glc , an integral membrane protein, blocks the action of Mlc by sequestering it at the inner membrane (27, 58) . We hypothesize that a similar interaction between Mlc and EIIBC Glc may block activation of EIIA Glc by Mlc (pathway 2a) (Fig. 14) . Our data also suggest that a small portion of the observed activation of vps gene transcription by Mlc may proceed through an EIIA Glcindependent pathway (pathway 2b) (Fig. 14) .
We identified two EIIA Ntr homologs that repress V. cholerae biofilm formation and vps gene transcription in LB broth but not in minimal medium (pathway 3) (Fig. 14) . Transcription of the EIIA Ntr homologs in these two media is similar. Therefore, this regulatory pathway is not controlled at the transcriptional level. The mechanism by which this pathway is activated remains to be identified.
We have not ruled out the possibility that there is an interaction between pathways 2 and 3. However, mutation of EIIA Ntr1 or EIIA Ntr2 in a ⌬EIIA Glc background activates biofilm formation (data not shown), suggesting that EIIA Ntr1 and EIIA Ntr2 act independent of EIIA Glc . While EIIA Ntr homologs have not been associated with biofilm formation in other organisms, they have been implicated in regulation of diverse metabolic functions, some of which have a clear role in regulating the balance of carbon and nitrogen in the cell. Two examples of this are repression of polyhydroxyalkanoate synthesis in Pseudomonas putida and repression of ␤-hydroxybutyrate synthesis in Azotobacter vinelandii by EIIA Ntr homologs (44, 62) . Both of these carbohydrate polymers are intracellular carbon storage compounds that are accumulated when the environmental carbohydrate supply exceeds the bacterial requirement. VPS, the extracellular polysaccharide which is a component of the V. cholerae biofilm matrix, may also play a role in carbohydrate balance. VPS synthesis is activated when PTS substrates are abundant and is repressed when PTS substrates become scarce (17) . Thus, in repressing VPS synthesis, V. cholerae EIIA Ntr may have a function parallel to that of its homologs in P. putida and A. vinelandii.
The mechanism by which EIIA Ntr represses polysaccharide synthesis in P. putida and A. vinelandii has not been discovered yet. However, the mechanism of action of EIIA Ntr in transcriptional derepression of the ilvBN operon, which encodes aceto- (25) . By an unknown mechanism, transcription of this operon is inhibited by high intracellular levels of K ϩ . The unphosphorylated form of EIIA Ntr inhibits the action of the K ϩ transporter TrkA, which keeps intracellular K ϩ levels low and preserves transcription of the ilvBN operon (24) . In our experiments, phosphorylation of neither EIIA Ntr1 nor EIIA Ntr2 was required for activation of vpsL gene transcription. One possibility is that regulation of gene transcription by EIIA Ntr in V. cholerae is governed by intracellular K ϩ levels in a phosphorylation stateindependent manner. Alternatively, EIIA Ntr may be involved in a regulatory interaction with a different protein.
There are several examples of V. cholerae functions that are governed by complex regulatory networks with multiple inputs. These functions include production of virulence factors (34) , quorum sensing (37), chemotaxis, and regulation of biofilm formation by cyclic-di-GMP (4, 5, 29, 57) . In each case, the mechanism by which various environmental signals are integrated and result in the observed phenotype is unknown. Regulation of biofilm formation in V. cholerae by the PTS also appears to be quite complex. Immediate goals include identification of the environmental signals to which pathways 2 and 3 respond, identification of downstream components of these pathways, and integration of the three pathways in regulation of biofilm formation by the PTS. In particular, it seems likely that these pathways eventually interface with members of the large family of V. cholerae proteins that modulate intracellular levels of c-di-GMP and whose activators remain largely unidentified.
The V. cholerae PTS participates in colonization of both environmental surfaces and the mammalian intestine (16) . We previously demonstrated that the influence of the PTS on VPSdependent biofilm formation does not play a role in colonization of the mammalian intestine. The regulatory pathways outlined here are hypothesized to participate in colonization of the environment. In particular, a close environmental relationship between V. cholerae and zooplankton has been demonstrated. V. cholerae is thought to degrade the chitinaceous exoskeletons of these organisms to N-acetylglucosamine, a sugar transported exclusively by the PTS (16) . Therefore, accumulation of V. cholerae on the exoskeletons of zooplankton is likely to be regulated by these PTS-dependent pathways. We envision that after formation of a monolayer on a surface, augmentation of the biofilm through cell division coupled with VPS synthesis is finely tuned to the nutritive potential of the surface itself and the environment in which the surface occurs. The signaling pathways outlined here contribute to bacterial sensing of surfaces and their environments and highlight the importance of PTS substrates in this process.
